Dr. Matthew J. DiMagno, MD, AGAF attended the University of Minnesota Medical School (1991-95), the University of Michigan Internal Medicine Residency Training Program (1995-98) and the University of Michigan Gastroenterology Training Program (1998-2001). He was appointed Lecturer at the University of Michigan (2001-07) where he was awarded and completed an NIH individual NRSA Post-doctoral fellowship focusing on experimental pancreatitis (2002-04). Currently, Dr. DiMagno is Associate Professor of Internal Medicine, Division of Gastroenterology at the University of Michigan (2017-), where he is a Medical Pancreatologist with expertise in clinical care and translational research in acute pancreatitis, chronic pancreatitis, exocrine pancreatic insufficiency and other pancreatic disorders. He is author/co-author of 58 peer-reviewed publications and book chapters and served in multiple leadership roles. He recently served as Chair of the American Gastroenterological Association Institute Council Pancreatic Disorders Section Committee (2014-16). Currently he serves as Medical Director, The National Pancreas Foundation State Chapter of Michigan; Gastroenterology Physician Liaison for the University of Michigan multidisciplinary Cystic Fibrosis center, supported by the Cystic Fibrosis Foundation Developing Innovative Gastroenterology Specialist Training program (2014-17); and Physician Liaison for the General Gastroenterology Clinic at the University of Michigan (2013-).
Dr. DiMagno has a longstanding interest in the susceptibility to pancreatitis conferred by genetic (e.g. CFTR gene mutations) and lifestyle (e.g. smoking and alcohol) risk factors. As an extension of these clinical interests, he has performed basic science research focused on the cellular and molecular mechanism of inflammation of the pancreas, funded by NIH. Dr. DiMagno has also published epidemiologic clinical studies focused on forms of acute and chronic pancreatitis, his primary focus of active research.